Wright Medical Group N.V. (WMGI)
Stock Price Chart
Key Info
| Market Cap | 3.98B |
| Revenue (ttm) | 809.53M |
| Net Income (ttm) | -134.11M |
| Shares Out | 129.68M |
| EPS (ttm) | -1.05 |
| PE Ratio | n/a |
| Forward PE | 83.33 |
| Dividend | n/a |
| Dividend Yield | n/a |
Stock Quote
| Trading Day | Oct 23, 2020 |
| Last Price | $30.66 |
| Previous Close | $30.64 |
| Change ($) | 0.02 |
| Change (%) | 0.07% |
| Day's Open | 30.63 |
| Day's Range | 30.62 - 30.68 |
| Day's Volume | 517,272 |
| 52-Week Range | 19.93 - 30.72 |
More Stats
| Market Cap | 3.98B |
| Enterprise Value | 5.05B |
| Earnings Date (est) | Nov 4, 2020 |
| Ex-Dividend Date | n/a |
| Shares Outstanding | 129.68M |
| Float | 127.97M |
| EPS (basic) | -1.05 |
| EPS (diluted) | -1.05 |
| FCF / Share | -0.48 |
| Dividend | n/a |
| Dividend Yield | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
| Payout Ratio | n/a |
| Shares Short | 17.26M |
| Short Ratio | 12.50 |
| Short % of Float | 13.49% |
| Beta | 0.64 |
| PE Ratio | n/a |
| Forward PE | 83.33 |
| P/FCF Ratio | n/a |
| PS Ratio | 4.91 |
| PB Ratio | 4.73 |
| Revenue | 809.53M |
| Operating Income | -38.99M |
| Net Income | -134.11M |
| Free Cash Flow | -61.89M |
| Net Cash | -1.08B |
| Net Cash / Share | -8.31 |
| Gross Margin | 90.58% |
| Operating Margin | -4.82% |
| Profit Margin | -16.60% |
| FCF Margin | -7.65% |
| ROA | -0.42% |
| ROE | -12.31% |
| ROIC | -3.50% |
Analyst Summary
Analyst Consensus: Hold
Financial Performance
Financial Overview
| Year | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 921 | 836 | 745 | 690 | 405 | 298 | 242 | 214 | 211 | 519 |
| Revenue Growth | 10.13% | 12.24% | 7.91% | 70.32% | 36% | 22.98% | 13.18% | 1.59% | -59.39% | - |
| Gross Profit | 732 | 656 | 584 | 498 | 292 | 225 | 183 | 166 | 153 | 361 |
| Operating Income | 11.59 | -7.80 | -19.69 | -123 | -189 | -99.81 | -282 | 11.82 | -0.73 | 37.17 |
| Net Income | -114 | -170 | -203 | -432 | -299 | -260 | -274 | 5.28 | -5.14 | 17.84 |
| Shares Outstanding | 127 | 113 | 105 | 103 | 64.81 | 51.29 | 48.10 | 38.77 | 38.28 | 37.80 |
| Earnings Per Share | -0.90 | -1.51 | -1.94 | -4.20 | -4.61 | -5.06 | -5.69 | 0.14 | -0.13 | 0.47 |
| Operating Cash Flow | 41.61 | -63.73 | -185 | 37.82 | -196 | -116 | -36.60 | 68.82 | 61.44 | 73.19 |
| Capital Expenditures | -99.29 | -71.47 | -63.47 | -50.10 | -43.67 | -48.60 | -37.53 | -19.32 | -46.96 | -49.04 |
| Free Cash Flow | -57.68 | -135 | -248 | -12.28 | -240 | -165 | -74.13 | 49.50 | 14.48 | 24.16 |
| Cash & Equivalents | 167 | 191 | 168 | 412 | 140 | 230 | 175 | 333 | 167 | 172 |
| Total Debt | 1,168 | 1,115 | 895 | 814 | 563 | 281 | 275 | 258 | 175 | 203 |
| Net Cash / Debt | -1,001 | -924 | -727 | -402 | -424 | -51.43 | -99.97 | 74.52 | -8.06 | -30.39 |
| Assets | 2,586 | 2,694 | 2,129 | 2,291 | 2,073 | 890 | 1,007 | 953 | 755 | 755 |
| Liabilities | 1,694 | 1,762 | 1,540 | 1,604 | 1,018 | 611 | 548 | 430 | 286 | 284 |
| Book Value | 892 | 932 | 589 | 687 | 1,055 | 279 | 460 | 523 | 468 | 471 |
Company Profile
Company Details
| Full Name | Wright Medical Group N.V. |
| Country | Netherlands |
| Employees | 3,030 |
| CEO | Robert J. Palmisano |
Stock Information
| Ticker Symbol | WMGI |
| Stock Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical Devices |
| Unique Identifier | NASDAQ: WMGI |
Description
Wright Medical Group N.V., a medical device company, designs, manufactures, markets, and sells upper and lower extremities, and biologics products in the United States, Europe, the Middle East, Africa, Canada, Asia, Australia, and Latin America. The company offers joint implants and bone fixation devices for the shoulder, elbow, wrist, hand, foot, and ankle; and biologics products that are used for supporting the treatment of damaged or diseased bones, tendons, and soft tissues, as well as to stimulate bone growth. It also provides sports medicines and other products to mechanically repair tissue-to-tissue or tissue-to-bone injuries, as well as other ancillary products. The company offers its products to orthopedic, trauma, and podiatric surgeons. It markets and sells its products through direct sales representatives, independent sales agencies, direct sales offices, and distributors. The company was founded in 1999 and is headquartered in Amsterdam, the Netherlands.